Chemoinformaics analysis of acid-phosphatase
| Molecular Weight | 208.213 | nRot | 4 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 8 |
| Exact Molecular Weight | 208.074 | nRing | 1 |
| Solubility: LogS | -2.423 | nHRing | 0 |
| Solubility: LogP | 2.07 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 29.5795 |
| nHD | 1 | BPOL | 16.3785 |
| QED | 0.766 |
| Synth | 1.687 |
| Natural Product Likeliness | 0.416 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.067 |
| HIA | 0.051 |
| CACO-2 | -4.682 |
| MDCK | 0.0000147 |
| BBB | 0.697 |
| PPB | 0.848406 |
| VDSS | 0.392 |
| FU | 0.093992 |
| CYP1A2-inh | 0.075 |
| CYP1A2-sub | 0.839 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.103 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.517 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.289 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.114 |
| CL | 7.717 |
| T12 | 0.918 |
| hERG | 0.026 |
| Ames | 0.044 |
| ROA | 0.142 |
| SkinSen | 0.946 |
| Carcinogencity | 0.479 |
| EI | 0.937 |
| Respiratory | 0.793 |
| NR-Aromatase | 0.07 |
| Antiviral | No |
| Prediction | 0.670835 |